Methotrexate in lieu of razoxane for incapacitating psoriasis.
作者信息
Steinman H K, Griffiths W A, Levene G M
出版信息
Lancet. 1984 Feb 25;1(8374):458-9. doi: 10.1016/s0140-6736(84)91798-7.
PMID:6142192
Abstract
摘要
相似文献
1
Methotrexate in lieu of razoxane for incapacitating psoriasis.甲氨蝶呤替代丙亚胺治疗重度银屑病。
Lancet. 1984 Feb 25;1(8374):458-9. doi: 10.1016/s0140-6736(84)91798-7.
2
Leukaemia in psoriatic patients treated with razoxane.接受丙亚胺治疗的银屑病患者中的白血病。
Br J Dermatol. 1984 May;110(5):633-4. doi: 10.1111/j.1365-2133.1984.tb04693.x.
3
Risk of leukemia associated with chemotherapy.与化疗相关的白血病风险。
Br Med J (Clin Res Ed). 1985 Feb 16;290(6467):555. doi: 10.1136/bmj.290.6467.555.
4
Epitheliomas in patients receiving razoxane therapy for psoriasis.接受丙亚胺治疗银屑病患者的上皮瘤
Br J Dermatol. 1983 Dec;109(6):675-8. doi: 10.1111/j.1365-2133.1983.tb00549.x.
5
Acute myeloid leukaemia after treatment with razoxane.
Br J Dermatol. 1985 Aug;113(2):131-4. doi: 10.1111/j.1365-2133.1985.tb02054.x.
6
Razoxane in the treatment of psoriasis.
Br J Dermatol. 1980 Nov;103(5):583-5. doi: 10.1111/j.1365-2133.1980.tb01675.x.
7
Razoxane: a review of 6 years' therapy in psoriasis.丙亚胺：对银屑病6年治疗情况的综述
Br J Dermatol. 1983 Dec;109(6):669-73. doi: 10.1111/j.1365-2133.1983.tb00548.x.
8
Leukaemia associated with razoxane.与丙亚胺相关的白血病。
Lancet. 1982 Jan 2;1(8262):44. doi: 10.1016/s0140-6736(82)92584-3.
9
Razoxane and acute promyelocytic leukaemia.
Lancet. 1987 Nov 7;2(8567):1085. doi: 10.1016/s0140-6736(87)91507-8.
10
Razoxane and leukaemia.丙亚胺与白血病
Lancet. 1984 Aug 4;2(8397):288-9. doi: 10.1016/s0140-6736(84)90330-1.
Zotero 插件